Peer Review reports
From: Apixaban dosing in hemodialysis - can drug level monitoring mitigate controversies?
| Original Submission | ||
|---|---|---|
| 10 Feb 2024 | Submitted | Original manuscript |
| 19 May 2024 | Reviewed | Reviewer Report |
| 4 Jun 2024 | Reviewed | Reviewer Report |
| 12 Jun 2024 | Author responded | Author comments - Simeon Schietzel |
| Resubmission - Version 2 | ||
| 12 Jun 2024 | Submitted | Manuscript version 2 |
| 18 Jun 2024 | Reviewed | Reviewer Report |
| 29 Jun 2024 | Reviewed | Reviewer Report |
| 2 Jul 2024 | Reviewed | Reviewer Report |
| 3 Jul 2024 | Reviewed | Reviewer Report |
| 23 Jul 2024 | Author responded | Author comments - Simeon Schietzel |
| Resubmission - Version 3 | ||
| 23 Jul 2024 | Submitted | Manuscript version 3 |
| 5 Aug 2024 | Reviewed | Reviewer Report |
| 23 Sep 2024 | Author responded | Author comments - Simeon Schietzel |
| Resubmission - Version 4 | ||
| 23 Sep 2024 | Submitted | Manuscript version 4 |
| 27 Sep 2024 | Reviewed | Reviewer Report |
| Resubmission - Version 5 | ||
| Submitted | Manuscript version 5 | |
| Publishing | ||
| 27 Sep 2024 | Editorially accepted | |
| 9 Oct 2024 | Article published | 10.1186/s12882-024-03782-w |
You can find further information about peer review here.